SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001824293-23-000041
Filing Date
2023-04-04
Accepted
2023-04-04 08:53:32
Documents
5

Document Format Files

Seq Description Document Type Size
1 425 axstockholdervotepressrele.htm 425 19140
2 EX-99.1 stockholdervote_pr040423.htm EX-99.1 17711
3 GRAPHIC image_0.jpg GRAPHIC 16879
4 GRAPHIC image_8.jpg GRAPHIC 1656
5 GRAPHIC logo_filings1.jpg GRAPHIC 95792
  Complete submission text file 0001824293-23-000041.txt   196320
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 607-8255
Vallon Pharmaceuticals, Inc. (Filed by) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 607-8255
Vallon Pharmaceuticals, Inc. (Subject) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40034 | Film No.: 23795248
SIC: 2834 Pharmaceutical Preparations